company background image
0QLQ logo

Ypsomed Holding LSE:0QLQ Stock Report

Last Price

CHF357.71

Market Cap

CHF4.9b

7D

2.9%

1Y

91.3%

Updated

26 Mar, 2024

Data

Company Financials +

0QLQ Stock Overview

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies.

0QLQ fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance4/6
Financial Health4/6
Dividends0/6

Ypsomed Holding AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ypsomed Holding
Historical stock prices
Current Share PriceCHF357.71
52 Week HighCHF375.50
52 Week LowCHF183.80
Beta0.99
1 Month Change0.36%
3 Month Change19.43%
1 Year Change91.33%
3 Year Change125.13%
5 Year Change178.36%
Change since IPO141.70%

Recent News & Updates

Recent updates

Shareholder Returns

0QLQGB Medical EquipmentGB Market
7D2.9%-2.1%2.1%
1Y91.3%0.8%3.8%

Return vs Industry: 0QLQ exceeded the UK Medical Equipment industry which returned 0.8% over the past year.

Return vs Market: 0QLQ exceeded the UK Market which returned 3.8% over the past year.

Price Volatility

Is 0QLQ's price volatile compared to industry and market?
0QLQ volatility
0QLQ Average Weekly Movement3.6%
Medical Equipment Industry Average Movement7.6%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0QLQ has not had significant price volatility in the past 3 months.

Volatility Over Time: 0QLQ's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19842,200Simon Michelhttps://www.ypsomed.com

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices.

Ypsomed Holding AG Fundamentals Summary

How do Ypsomed Holding's earnings and revenue compare to its market cap?
0QLQ fundamental statistics
Market capCHF4.91b
Earnings (TTM)CHF72.42m
Revenue (TTM)CHF508.61m

67.8x

P/E Ratio

9.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0QLQ income statement (TTM)
RevenueCHF508.61m
Cost of RevenueCHF345.64m
Gross ProfitCHF162.96m
Other ExpensesCHF90.55m
EarningsCHF72.42m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

May 22, 2024

Earnings per share (EPS)5.31
Gross Margin32.04%
Net Profit Margin14.24%
Debt/Equity Ratio35.4%

How did 0QLQ perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

24%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.